(Q46876506)

26 December 2017

title

The effects of curcumin on the invasiveness of prostate cancer in vitro and in vivo (English)

1 reference

26 December 2017

main subject

curcumin

0 references

neoplastic invasiveness

1 reference

1 reference

Hong JH

1 reference

26 December 2017

Ahn KS

1 reference

26 December 2017

Bae E

1 reference

26 December 2017

Jeon SS

1 reference

26 December 2017

Choi HY

1 reference

26 December 2017

publication date

3 January 2006

1 reference

26 December 2017

Prostate Cancer and Prostatic Diseases

published in

1 reference

26 December 2017

volume

1 reference

26 December 2017

issue

1 reference

26 December 2017

page(s)

147-152

1 reference

26 December 2017

cites work

Cancer statistics, 2004

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500856

Diet and its preventive role in prostatic disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500856

Nutritional and socioeconomic factors in relation to prostate cancer mortality: a cross-national study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500856

Matrix metalloproteinases. Novel targets for directed cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500856

The role of matrix metalloproteinases in tumor angiogenesis and tumor metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500856

Type IV collagenase (matrix metalloproteinase-2 and -9) in prostate cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500856

Therapeutic potential of curcumin in human prostate cancer-I. curcumin induces apoptosis in both androgen-dependent and androgen-independent prostate cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500856

Therapeutic potential of curcumin in human prostate cancer. III. Curcumin inhibits proliferation, induces apoptosis, and inhibits angiogenesis of LNCaP prostate cancer cells in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500856

Curcumin downregulates cell survival mechanisms in human prostate cancer cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500856

Therapeutic potential of curcumin in prostate cancer--V: Interference with the osteomimetic properties of hormone refractory C4-2B prostate cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500856

Phytoestrogens in common herbs regulate prostate cancer cell growth in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500856

EF24, a novel synthetic curcumin analog, induces apoptosis in cancer cells via a redox-dependent mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500856

Matrix metalloproteinases as diagnostic (MMP-13) and prognostic (MMP-2, MMP-9) markers of prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500856

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1038/SJ.PCAN.4500856

1 reference

26 December 2017

1 reference

26 December 2017